- Home
- LXFR vs RNAC Comparison
LXFR vs RNAC Comparison
Compare LXFR & RNAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LXFR
- RNAC
- Stock Information
- Founded
- LXFR 1898
- RNAC 2007
- Country
- LXFR United States
- RNAC United States
- Employees
- LXFR N/A
- RNAC N/A
- Industry
- LXFR Major Chemicals
- RNAC Biotechnology: Pharmaceutical Preparations
- Sector
- LXFR Industrials
- RNAC Health Care
- Exchange
- LXFR Nasdaq
- RNAC Nasdaq
- Market Cap
- LXFR 335.4M
- RNAC 276.3M
- IPO Year
- LXFR 2012
- RNAC 2016
- Fundamental
- Price
- LXFR $13.42
- RNAC $10.05
- Analyst Decision
- LXFR
- RNAC Strong Buy
- Analyst Count
- LXFR 0
- RNAC 4
- Target Price
- LXFR N/A
- RNAC $40.00
- AVG Volume (30 Days)
- LXFR 132.0K
- RNAC 46.5K
- Earning Date
- LXFR 10-28-2025
- RNAC 08-07-2025
- Dividend Yield
- LXFR 3.91%
- RNAC N/A
- EPS Growth
- LXFR N/A
- RNAC N/A
- EPS
- LXFR 0.90
- RNAC N/A
- Revenue
- LXFR $403,800,000.00
- RNAC $1,026,000.00
- Revenue This Year
- LXFR $3.12
- RNAC N/A
- Revenue Next Year
- LXFR $3.31
- RNAC N/A
- P/E Ratio
- LXFR $14.77
- RNAC N/A
- Revenue Growth
- LXFR 5.60
- RNAC N/A
- 52 Week Low
- LXFR $9.41
- RNAC $8.46
- 52 Week High
- LXFR $15.64
- RNAC $26.50
- Technical
- Relative Strength Index (RSI)
- LXFR 64.00
- RNAC 34.71
- Support Level
- LXFR $12.32
- RNAC $10.50
- Resistance Level
- LXFR $13.86
- RNAC $11.80
- Average True Range (ATR)
- LXFR 0.45
- RNAC 0.56
- MACD
- LXFR 0.11
- RNAC -0.11
- Stochastic Oscillator
- LXFR 78.85
- RNAC 0.45
About LXFR Luxfer Holdings PLC
Luxfer Holdings PLC is a manufacturer industrial company innovating niche applications in materials engineering. It focuses on value creation by using its broad array of technical know-how and proprietary technologies to help create a safe, clean, and energy-efficient world. Luxfer's high-performance materials, components, and high-pressure gas containment devices are used in defense, first response and healthcare, transportation, and general industrial applications. It focuses on product lines related to magnesium alloys, zirconium chemicals, and carbon composites. Its segments are Elektron, Gas Cylinders, and Graphic Arts. It generates the majority of its revenue from Elektron and as well as Gas Cylinders.
About RNAC Cartesian Therapeutics Inc.
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. The company leverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function.